Severe influenza A(H1N1)2009 infection: A single centre experience and review of the literature

Acta Clinica Belgica

Volumn 67, Issue 1, 2011, Pages 1-6

  Van Ierssel, S H ^a   Ieven, M ^a   Jorens, Philippe G ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

H1N1; Influenza A; Intensive care critical care; Severe influenza

Indexed keywords

CORTICOSTEROID; LANINAMIVIR; NITRIC OXIDE; OSELTAMIVIR; PERAMIVIR; PROCALCITONIN; RIBAVIRIN; ZANAMIVIR;

2009 H1N1 INFLUENZA; ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG MEGADOSE; ENCEPHALITIS; EXTRACORPOREAL OXYGENATION; HEART MUSCLE INJURY; HIGH FREQUENCY VENTILATION; HIGH RISK PATIENT; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; LUNG LAVAGE; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; PREGNANT WOMAN; PROGNOSIS; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEASONAL INFLUENZA; THORAX RADIOGRAPHY; VIRUS TRANSMISSION;

ADULT; AGED; ANTIVIRAL AGENTS; BELGIUM; CHILD; COHORT STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE; MALE; MIDDLE AGED; PANDEMICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84862580549     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.2143/ACB.67.1.2062618     Document Type: Review

References (49)

1. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March- April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 467-470.
2. Amato-Gauci A, Zucs P, Snacken R, et al. Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe. Euro Surveill 2011; 16.
3. Influenza A(H1N1)v virus infections in Belgium, May-June 2009. Euro Surveill 2009; 14: pii=19270.
4. Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk Factors for Severe Outcomes following 2009 influenza A (H1N1) Infection: A Global Pooled Analysis. PLoS Med 2011; 8: e1001053.
5. European centre for disease Prevention and Control (ECDC). ECDC Risk assessment: seasonal influenza 2010-2011 in Europe (EU/EEA countries). 2011.
6. Review of the 2010-2011 winter influenza season, northern hemisphere. Wkly Epidemiol Rec 2011; 86: 222-227.
7. Ellis J, Galiano M, Pebody R, et al. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 2011; 16 pii=19760.
8. http://influenza.wiv-isp.be/nl/syndromicsurveillance/Pages/default.aspx. 2011.
9. Tang JW, Shetty N, Lam TT. Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects. Curr Opin Pulm Med 2010; 16: 235-241.
10. Venkata C, Sampathkumar P, Afessa B. Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc 2010; 85: 798-805.
11. World Health Organisation (WHO). Clinical management of human infections with pandemic (H1N1) 2009: revised guidance. 2009. http://www.who.int/csr/ resources/publications/swineflu/clinical-management-h1n1.pdf, World Health Organisation (WHO).
12. Akins PT, Belko J, Uyeki TM, et al. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care 2010; 13: 396-406.
13. Chacko B, Peter JV, Pichamuthu K, et al. Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care. J Crit Care 2011 [Epub ahead of print].
14. Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010; 182: 41-48.
15. Rello J, Rodriguez A, Ibanez P, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009; 13: R148.
16. Riscili BP, Anderson TB, Prescott HC, et al. An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics. PLoS One 2011; 6: e18166.
17. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010; 38: e91-e97.
18. Jean C, Louie JK, Glaser CA, et al. Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clin Infect Dis 2010; 50: e59-e62.
19. Zakikhany K, Degail MA, Lamagni T, et al. Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill 2011; 16.
20. Boggild AK, McGeer AJ. Laboratory diagnosis of 2009 H1N1 influenza A virus. Crit Care Med 2010; 38: e38-e42.
21. Aviram G, Bar-Shai A, Sosna J, et al. H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology 2010; 255: 252-259.
22. Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011; 37: 796-800.
23. Piacentini E, Sanchez B, Arauzo V, et al. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community- acquired bacterial pneumonia. A pilot study. J Crit Care 2011; 26: 201-205.
24. World Health Organisation (WHO). WHO Guidelines for the Pharmacological Management of Pandemic influenza A (H1N1) 2009 and other influenza Viruses. Part I: Recommendations. 2010. World Health Organisation (WHO).
25. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303: 1517-1525.
26. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 521-526.
27. Choi SM, Boudreault AA, Xie H, et al. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011; 117: 5050-5056.
28. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65: 510-515.
29. Meschi S, Selleri M, Lalle E, et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis 2011; 11: 140.
30. Ljungman P, de la Camara R, Perez-Bercoff L, et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 2011; 96: 1231-1235.
31. Smith JR, Ariano RE, Toovey S. The use of antiviral agents for the management of severe influenza. Crit Care Med 2010; 38: e43-e51.
32. Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011; 37: 272-283.
33. Kim SH, Hong SB, Yun SC, et al. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011; 183: 1207-1214.
34. Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183: 1200-1206.
35. Ramsey CD, Funk D, Miller RR, III, Kumar A. Ventilator management for hypoxemic respiratory failure attributable to H1N1 novel swine origin influenza virus. Crit Care Med 2010; 38: e58-e65.
36. Park PK, Napolitano LM, Bartlett RH. Extracorporeal membrane oxygenation in adult acute respiratory distress syndrome. Crit Care Clin 2011; 27: 627-646.
37. Mitchell MD, Mikkelsen ME, Umscheid CA, et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010; 38: 1398-1404.
38. Peek GJ, Mugford M, Tiruvoipati R, et al. Efcacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363.
39. Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302: 1888-1895.
40. Martin-Loeches I, Papiol E, Rodriguez A, et al. Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection. Crit Care 2011; 15: R66.
41. Pettila V, Webb SA, Bailey M, et al. Acute kidney injury in patients with influenza A (H1N1) 2009. Intensive Care Med 2011; 37: 763-767.
42. Akritidis N, Mastora M, Baxevanos G, Dimos G, Pappas G. Electrocardiographic abnormalities in patients with novel H1N1 influenza virus infection. Am J Cardiol 2010; 106: 1517-1519.
43. Beutel G, Wiesner O, Eder M, et al. Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care 2011; 15: R80.
44. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis 2008; 14: 95-100.
45. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011; 342: d3214.
46. Mirochnick M, Clarke D. Oseltamivir pharmacokinetics in pregnancy: a commentary. Am J Obstet Gynecol 2011; 204: S94-S95.
47. Nair P, Davies AR, Beca J, et al. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med 2011; 37: 648-654.
48. Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011; 204: S141-S148
49. Cordero E, Perez-Romero P, Moreno A, et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral coinfection. Clin Microbiol Infect 2011 [Epub ahead of print].